Ruane, Cunniff & Goldfarb’s Pfizer PFE Stock Holding History

Ruane, Cunniff & Goldfarb’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-6,250	Closed	-$209K	–	108
2016 Q2	$209K	Sell	6,250 -6,864	-52%	-$219K	﹤0.01%	114
2016 Q1	$369K	Sell	13,114 -2,538	-16%	-$72.5K	﹤0.01%	118
2015 Q4	$479K	Buy	15,652 +3,740	+31%	+$118K	﹤0.01%	116
2015 Q3	$355K	Buy	11,912 +353	+3%	+$11.3K	﹤0.01%	123
2015 Q2	$368K	Hold	11,559	–	–	﹤0.01%	125
2015 Q1	$382K	Hold	11,559	–	–	﹤0.01%	125
2014 Q4	$342K	Hold	11,559	–	–	﹤0.01%	129
2014 Q3	$324K	Sell	11,559 -21	-0.2%	-$589	﹤0.01%	135
2014 Q2	$326K	Sell	11,580 -37	-0.3%	-$1.05K	﹤0.01%	127
2014 Q1	$354K	Hold	11,617	–	–	﹤0.01%	120
2013 Q4	$338K	Buy	11,617 +632	+6%	+$18.4K	﹤0.01%	126
2013 Q3	$299K	Hold	10,985	–	–	﹤0.01%	129
2013 Q2	$292K	Buy	+10,985	New	+$304K	﹤0.01%	123

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ruane, Cunniff & Goldfarb's PFE Position: Q3 2016 in Review

Ruane, Cunniff & Goldfarb sold out of Pfizer (PFE) in Q3 2016, closing a stake of 6,250 shares — an estimated $209K sold.

Ruane, Cunniff & Goldfarb first reported a position in PFE in Q2 2013 and held it in 13 quarters. The position peaked at $479K in Q4 2015. 1,962 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

Ruane, Cunniff & Goldfarb reported no remaining Pfizer position as of Q3 2016 after selling out during the quarter.
Ruane, Cunniff & Goldfarb sold 6,250 Pfizer shares in Q3 2016, an estimated $209K.
Ruane, Cunniff & Goldfarb first reported a position in Pfizer in Q2 2013 and held it in 13 quarters.
Ruane, Cunniff & Goldfarb's Pfizer position peaked at $479K in Q4 2015.
1,962 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Ruane, Cunniff & Goldfarb's 13F filing for Q3 2016, filed 14 Nov 2016.